Clinical trial

An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes

NCT01400971

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2011-07-01

PhaseN/A

Study timeline

Study start (unknown)2011-07-01Date precision: month

Registry last updated2020-03-09

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetes Mellitus, Type 2unresolved

Interventions

Sponsors & collaborators

Eli Lilly and Companylead sponsor

Mapped research locations

HoustonTexas, United States1 DallasTexas, United States1 MadridSpain1 BarcelonaSpain1 MontrealQuebec, Canada1 OrlandoFlorida, United States1 CharlestonSouth Carolina, United States1 MoscowRussia1 RichmondVirginia, United States1 BeijingChina1 HamburgGermany1 Saint PetersburgRussia1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01400971 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.